Selective Itk Inhibitors Block T-Cell Activation and Murine Lung Inflammation
Tai-An Lin, Kim W. McIntyre, Jagabandhu Das et al. · Biochemistry · 2004
Nonreceptor protein tyrosine kinases including Lck, ZAP-70, and Itk play essential roles in T-cell receptor (TCR) signaling. Gene knockout studies have revealed that mice lacking these individual kinases exhibit various degrees of immunodeficiency; however, highly selective small molecule inhibitors of these kinases as potential immunosuppressive agents have not been identified. Here we discovered two novel compounds, BMS-488516 and BMS-509744, that potently and selectively inhibit Itk kinase activity. The compounds reduce TCR-induced functions including PLCgamma1 tyrosine phosphorylation, calcium mobilization, IL-2 secretion, and T-cell proliferation in vitro in both human and mouse cells. The inhibitors suppress the production of IL-2 induced by anti-TCR antibody administered to mice. BMS-509744 also significantly diminishes lung inflammation in a mouse model of ovalbumin-induced allergy/asthma. Our findings represent the first description of selective inhibitors to probe human Itk function and its associated pathway, and support the hypothesis that Itk is a therapeutic target for immunosuppressive and inflammatory diseases.
Cited by 111 works. doi:10.1021/bi049428r
Authors
- Tai-An Lin
- Kim W. McIntyre
- Jagabandhu Das
- Chunjian Liu
- Kathleen O'Day
- Becky A. Penhallow
- Chen-Yi Hung
- Gena S. Whitney
- David J. Shuster
- Xiao-Xia Yang
- Jennifer Postelnek
- Steven H. Spergel
- James C. Lin
- Robert V. Moquin
- Joseph A. Furch
- Amrita V. Kamath
- Hongjian Zhang
- Punit H. Marathe
- Juan J. Pérez‐Villar
References
- Profound block in thymocyte development in mice lacking p56lck
- Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity.
- T-cell signalling and autoimmunity: molecular mechanisms of disease
- Attenuation of Immunological Symptoms of Allergic Asthma in Mice Lacking the Tyrosine Kinase ITK
- Emerging immune targets for the therapy of allergic asthma
- The T Cell Antigen Receptor